{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:58:43Z","timestamp":1790287123174,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101072","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:20:34Z","timestamp":1785342034000},"page":"101072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in the Management of Refractory Helicobacter pylori Infection: From Antimicrobial Resistance to Precision Eradication"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3800-6044","authenticated-orcid":false,"given":"Bo","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2026.101072_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.gastha.2026.101072_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.gastha.2026.101072_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/5584_2019_363","article-title":"Malignant Helicobacter pylori-Associated diseases: Gastric cancer and MALT lymphoma","volume":"1149","author":"Hatakeyama","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.gastha.2026.101072_bib6","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.101072_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib8","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1097\/CM9.0000000000002546","article-title":"2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment","volume":"135","author":"Zhou","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.gastha.2026.101072_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","article-title":"Helicobacter pylori World Gastroenterology Organization Global guideline","volume":"57","author":"Katelaris","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2023.09.047","article-title":"Evolving concepts in Helicobacter pylori management","volume":"166","author":"Moss","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.14309\/ajg.0000000000002045","article-title":"Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe","volume":"118","author":"M\u00e9graud","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib12","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review","volume":"160","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00258-21","article-title":"Helicobacter pylori infection, its laboratory diagnosis, and antimicrobial resistance: a perspective of clinical relevance","volume":"35","author":"Ansari","year":"2022","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.gastha.2026.101072_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101217","article-title":"Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study","volume":"7","author":"Mart\u00ednez-Mart\u00ednez","year":"2026","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.gastha.2026.101072_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107325","article-title":"Antibiotic resistance of Helicobacter pylori in mainland China: a focus on geographic differences through systematic review and meta-analysis","volume":"64","author":"Zeng","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.gastha.2026.101072_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13057","article-title":"Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: a systematic review","volume":"29","author":"Dutta","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.14309\/ajg.0000000000001828","article-title":"Helicobacter pylori antibiotic resistance in the United States between 2011 and 2021: a systematic review and meta-analysis","volume":"117","author":"Ho","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib18","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","volume":"74","author":"Schulz","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.101072_bib19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jgh.13906","article-title":"rdxA, frxA, and efflux pump in metronidazole-resistant Helicobacter pylori: their relation to clinical outcomes","volume":"33","author":"Lee","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/1040841X.2024.2364194","article-title":"Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings","volume":"51","author":"Umar","year":"2025","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00101-25","article-title":"Mutation-based mechanisms of antibiotic resistance","volume":"90","author":"Misra","year":"2026","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.gastha.2026.101072_bib22","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s10620-009-0748-x","article-title":"Is furazolidone therapy for Helicobacter pylori effective and safe?","volume":"54","author":"De Francesco","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2026.101072_bib23","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/17512433.2023.2282061","article-title":"Advances in the pharmacological and regulatory management of multidrug resistant Helicobacter pylori","volume":"16","author":"Rokkas","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.gastha.2026.101072_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1128497","article-title":"Multidrug resistance in Helicobacter pylori infection","volume":"14","author":"Dasc\u0103lu","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jconrel.2025.01.054","article-title":"Antibiotic-free responsive biomaterials for specific and targeted Helicobacter pylori eradication","volume":"379","author":"Zheng","year":"2025","journal-title":"J Control Release"},{"key":"10.1016\/j.gastha.2026.101072_bib26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/antibiotics12081260","article-title":"Biofilm of Helicobacter pylori: life cycle, features, and treatment options","volume":"12","author":"Elshenawi","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib27","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.2147\/IJN.S512066","article-title":"Nanomaterials: a prospective strategy for biofilm-forming Helicobacter pylori treatment","volume":"20","author":"Meng","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.gastha.2026.101072_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2566964","article-title":"Coccoid H. Pylori: a key driver of recurrent infections and a target for novel therapies","volume":"16","author":"Sadeghloo","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.gastha.2026.101072_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.59249\/KTAJ7963","article-title":"Determination of genes vacA and cagA in Helicobacter pylori and their relationship with the induction of coccoid forms in isolates from patients in Antioquia, Colombia","volume":"98","author":"Chaparro-Ortega","year":"2025","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.gastha.2026.101072_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/antibiotics9060293","article-title":"The puzzle of coccoid forms of Helicobacter pylori: beyond basic","volume":"9","author":"Ierardi","year":"2020","journal-title":"Sci Antibiot (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib31","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.3748\/wjg.v29.i19.2950","article-title":"Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases","volume":"29","author":"Asaad","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12879-022-07546-5","article-title":"Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis","volume":"22","author":"Karbalaei","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gastha.2026.101072_bib33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1053\/j.gastro.2021.07.043","article-title":"Host genetic determinants associated with Helicobacter pylori eradication treatment failure: a systematic review and meta-analysis","volume":"161","author":"Shah","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib34","article-title":"Effects of CYP2C19 genetic polymorphisms on the cure rates of H. pylori in patients treated with the proton pump inhibitors: an updated meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.gastha.2026.101072_bib35","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ueg2.12569","article-title":"Role of compliance in Helicobacter pylori eradication treatment: results of the European Registry on H. pylori management","volume":"12","author":"Huguet","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.gastha.2026.101072_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2021.10.048","article-title":"How we approach difficult to eradicate Helicobacter pylori","volume":"162","author":"Argueta","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122540","article-title":"An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection","volume":"308","author":"Sun","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.gastha.2026.101072_bib38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1080\/00325481.2022.2105094","article-title":"Impact of insufficient doses of medications on Helicobacter pylori eradication: a retrospective observational study","volume":"134","author":"Shi","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.gastha.2026.101072_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.19818","article-title":"Navigating drug interactions with proton pump inhibitors","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.gastha.2026.101072_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100880","article-title":"Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure","volume":"8","author":"Raoul","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.gastha.2026.101072_bib41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/clinchem\/hvac082","article-title":"Single-cell identification, drug susceptibility test, and whole-genome sequencing of Helicobacter pylori directly from gastric biopsy by clinical antimicrobial susceptibility test ramanometry","volume":"68","author":"Liu","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.gastha.2026.101072_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70007","article-title":"Advances in Helicobacter pylori antimicrobial resistance detection: from culture-based to multi-omics-based technologies","volume":"30","author":"Kuang","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/antibiotics13080786","article-title":"Rapid phenotypic and genotypic antimicrobial susceptibility testing approaches for use in the clinical laboratory","volume":"13","author":"Hattab","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib44","first-page":"243","article-title":"Helicobacter pylori culture: from bench to bedside","volume":"35","author":"Zullo","year":"2022","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib45","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i32.106424","article-title":"Novel chromogenic medium-based method for the rapid detection of Helicobacter pylori drug resistance","volume":"31","author":"Guan","year":"2025","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.51821\/86.1.11327","article-title":"Belgian consensus for Helicobacter pylori management 2023","volume":"86","author":"Garc\u00e9s-Duran","year":"2023","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.gastha.2026.101072_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S2468-1253(23)00113-9","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori comes of age","volume":"8","author":"O'Morain","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-0716-1302-3_6","article-title":"Culture-based antimicrobial susceptibility testing for Helicobacter pylori","volume":"2283","author":"Lehours","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.gastha.2026.101072_bib49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/antibiotics14121223","article-title":"Resistance to clarithromycin and fluoroquinolones in Helicobacter pylori isolates: a prospective molecular analysis in Western Romania","volume":"14","author":"Serena","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70012","article-title":"The accuracy of melting curve-based multiplex real-time PCR for diagnosing Helicobacter pylori resistance to clarithromycin and levofloxacin in stool specimens","volume":"30","author":"Wang","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib51","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/MEG.0000000000002796","article-title":"The second Irish Helicobacter pylori working group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland","volume":"36","author":"Smith","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib52","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/JCM.01997-06","article-title":"Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR","volume":"45","author":"Nishizawa","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib53","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1440-1746.2006.04546.x","article-title":"Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method","volume":"22","author":"Nakamura","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01034-24","article-title":"Comparative analysis of the detection of antibiotic genotypic resistance with gastric mucosa, gastric fluid, and fecal samples in patients with Helicobacter pylori infection","volume":"63","author":"Ren","year":"2025","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ueg2.12473","article-title":"The use of non-invasive stool tests for verification of Helicobacter pylori eradication and clarithromycin resistance","volume":"11","author":"Mommersteeg","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.gastha.2026.101072_bib56","article-title":"Clinical evaluation of a real-time PCR assay for simultaneous detection of Helicobacter pylori and genotypic markers of clarithromycin resistance directly from stool","volume":"59","author":"Marrero","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12958","article-title":"Individualized diagnosis and eradication therapy for Helicobacter pylori infection based on gene detection of clarithromycin resistance in stool specimens: a systematic review and meta-analysis","volume":"28","author":"Ren","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib58","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1038\/s41598-025-32968-x","article-title":"Comparative molecular profiling of Helicobacter pylori infection and antibiotic genotypic resistance in paired gastric mucosa, gastric juice, and stool samples","volume":"16","author":"Cheng","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.gastha.2026.101072_bib59","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1053\/j.gastro.2022.02.027","article-title":"Comparable results of Helicobacter pylori antibiotic resistance testing of stools vs gastric biopsies using next-generation sequencing","volume":"162","author":"Moss","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/antibiotics10040437","article-title":"Next generation sequencing for the prediction of the antibiotic resistance in helicobacter pylori: a literature review","volume":"10","author":"Saracino","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib61","first-page":"469","article-title":"Helicobacter pylori antimicrobial resistance and the role of next-generation sequencing","volume":"20","author":"Andrews","year":"2024","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.gastha.2026.101072_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01834-18","article-title":"Helicobacter pylori mutations detected by next-generation sequencing in formalin-fixed, paraffin-embedded gastric biopsy specimens are associated with treatment failure","volume":"57","author":"Nezami","year":"2019","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116884","article-title":"Cas14VIDet: a visual instant method free from PAM restriction for antibiotic resistance bacteria detection","volume":"268","author":"Lai","year":"2025","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.gastha.2026.101072_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2026.118438","article-title":"Point-of-care profiling of H. pylori virulence and antibiotic resistance from endoscopic biopsies using an integrated restriction enzyme-CRISPR microfluidic platform","volume":"299","author":"Xu","year":"2026","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.gastha.2026.101072_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.gastro.2026.02.041","article-title":"The unfinished agenda in Helicobacter pylori treatment: resistance, microbiome effects, and future directions","volume":"171","author":"Rokkas","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib66","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/antibiotics11101452","article-title":"Clinical implications of Helicobacter pylori antibiotic resistance in Italy: a review of the literature","volume":"11","author":"Nista","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70056","article-title":"Vonoprazan improves efficacy of bismuth quadruple therapy for Helicobacter pylori rescue treatment: a multicenter randomized controlled trial","volume":"30","author":"Yan","year":"2025","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jiad114","article-title":"Rifabutin-containing triple therapy versus bismuth quadruple therapy for Helicobacter pylori rescue treatment: a multicenter, randomized controlled trial","volume":"228","author":"Chen","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.gastha.2026.101072_bib69","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/CM9.0000000000002289","article-title":"Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial","volume":"135","author":"Bi","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.gastha.2026.101072_bib70","article-title":"Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis","volume":"12","author":"Lv","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gastha.2026.101072_bib71","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2026.01.008","article-title":"Vonoprazan-tetracycline dual regimen as rescue therapy for Helicobacter pylori infection: randomized controlled trial","volume":"170","author":"Gao","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib72","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/ajg.2017.195","article-title":"Ten-day quadruple therapy comprising proton pump inhibitor, bismuth, tetracycline, and levofloxacin is more effective than standard levofloxacin triple therapy in the second-line treatment of Helicobacter pylori infection: a randomized controlled trial","volume":"112","author":"Hsu","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1751-2980.12498","article-title":"Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori","volume":"18","author":"Wu","year":"2017","journal-title":"J Dig Dis"},{"key":"10.1016\/j.gastha.2026.101072_bib74","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.3748\/wjg.v24.i40.4596","article-title":"Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication","volume":"24","author":"Zhang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib75","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/jgh.15468","article-title":"Clarithromycin versus furazolidone for na\u00efve Helicobacter pylori infected patients in a high clarithromycin resistance area","volume":"36","author":"Qiao","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2026.101072_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1652943","article-title":"Therapeutic advances and future directions in Helicobacter pylori eradication","volume":"16","author":"Suresh","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9794901","article-title":"The efficacy, safety, and tolerability of levofloxacin quadruple therapy for Helicobacter pylori eradication: a randomized, double-blind clinical trial","volume":"2022","author":"Mansour-Ghanaei","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.gastha.2026.101072_bib78","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13712","article-title":"Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection","volume":"44","author":"Chen","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2026.101072_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","article-title":"The Toronto consensus for the treatment of Helicobacter pylori infection in adults","volume":"151","author":"Fallone","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib80","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3748\/wjg.v29.i2.390","article-title":"Third-line and rescue therapy for refractory Helicobacter pylori infection: a systematic review","volume":"29","author":"de Moraes Andrade","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib81","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.dld.2022.06.019","article-title":"Management of Helicobacter pylori infection: guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)","volume":"54","author":"Romano","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.gastha.2026.101072_bib82","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13099-026-00802-y","article-title":"Clinical impact of high-dose esomeprazole-amoxicillin dual therapy as rescue treatment for Helicobacter pylori infection: a meta-analysis of randomized controlled trials","volume":"18","author":"Khan","year":"2026","journal-title":"Gut Pathog"},{"key":"10.1016\/j.gastha.2026.101072_bib83","first-page":"1028","article-title":"Rescue therapy with furazolidone in patients with at least five eradication treatment failures and multi-resistant H","volume":"10","author":"Resina","year":"2021","journal-title":"Pylori Infection. Antibiot (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib84","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40265-023-01991-5","article-title":"Vonoprazan: a review in Helicobacter pylori infection","volume":"84","author":"Shirley","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.gastha.2026.101072_bib85","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s12325-016-0345-2","article-title":"Characteristics of the novel potassium-competitive acid blocker vonoprazan fumarate (TAK-438)","volume":"33","author":"Otake","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.gastha.2026.101072_bib86","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan triple and dual therapy for Helicobacter pylori infection in the United States and Europe: randomized clinical trial","volume":"163","author":"Chey","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2026.101072_bib87","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2023-329826","article-title":"Vonoprazan-based versus proton pump inhibitor-based therapy in Helicobacter pylori eradication: an updated systematic review and meta-analysis of randomised trials","volume":"73","author":"Chen","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.101072_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13148","article-title":"Efficacy and safety of vonoprazan in dual\/triple\/quadruple regimens both in first-line and rescue therapy for Helicobacter pylori eradication: a systematic review with meta-analysis","volume":"29","author":"Benito","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib89","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00535-022-01942-z","article-title":"Efficacy and safety of vonoprazan-based regimen for Helicobacter pylori eradication therapy in Japanese adolescents: a prospective multicenter study","volume":"58","author":"Kakiuchi","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.gastha.2026.101072_bib90","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70112","article-title":"Efficacy and safety of vonoprazan-based dual, triple, and quadruple therapies for Helicobacter pylori eradication: a randomized controlled trial","volume":"31","author":"Zhang","year":"2026","journal-title":"Helicobacter"},{"key":"10.1016\/j.gastha.2026.101072_bib91","first-page":"927","article-title":"Expert consensus on the clinical application of bifidobacterium tetravaccine tablets for digestive diseases","volume":"63","year":"2024","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.gastha.2026.101072_bib92","article-title":"N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication","volume":"2","author":"Fontes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gastha.2026.101072_bib93","article-title":"Vitamins and helicobacter pylori: an updated comprehensive meta-analysis and systematic review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.gastha.2026.101072_bib94","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/ph17111537","article-title":"Antibacterial mechanisms and clinical impact of sitafloxacin","volume":"17","author":"Kuhn","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.gastha.2026.101072_bib95","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/jcm10122722","article-title":"Sitafloxacin for third-line Helicobacter pylori eradication: a systematic review","volume":"10","author":"Nishizawa","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.gastha.2026.101072_bib96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/1040841X.2025.2554619","article-title":"Helicobacter pylori eradication: developing antibiotic-independent antimicrobial moieties","volume":"52","author":"Yan","year":"2026","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib97","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/pathogens13050392","article-title":"Helicobacter pylori outer membrane proteins and virulence factors: potential targets for novel therapies and vaccines","volume":"13","author":"Sedarat","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.gastha.2026.101072_bib98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/1040841X.2021.1975643","article-title":"Helicobacter pylori infection: from standard to alternative treatment strategies","volume":"48","author":"Sousa","year":"2022","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.gastha.2026.101072_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101183","article-title":"Vaccination against Helicobacter pylori - an approach for cancer prevention?","volume":"92","author":"Friedrich","year":"2023","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.gastha.2026.101072_bib100","article-title":"Developing a potent vaccine against helicobacter pylori: critical considerations and challenges","volume":"27","author":"Hasanzadeh Haghighi","year":"2024","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.gastha.2026.101072_bib101","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1038\/s41467-025-61329-5","article-title":"The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations","volume":"16","author":"Higgins","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2026.101072_bib102","article-title":"Effect of a WeChat-based medication reminder platform on Helicobacter pylori therapy","volume":"13","author":"Huang","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.gastha.2026.101072_bib103","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1016\/S2666-5247(24)00027-2","article-title":"Multicentre, cross-sectional surveillance of Helicobacter pylori prevalence and antibiotic resistance to clarithromycin and levofloxacin in urban China using the string test coupled with quantitative PCR","volume":"5","author":"Wang","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.gastha.2026.101072_bib104","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus","volume":"69","author":"Liou","year":"2020","journal-title":"Gut"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:59:04Z","timestamp":1790283544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":104,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001937"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101072","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Management of Refractory Helicobacter pylori Infection: From Antimicrobial Resistance to Precision Eradication","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101072"}}